Our monthly round-up of Ipsos research and thinking reflects on the world one year on from Covid-19, looks forward to the world in 2025 and beyond, and presents new white papers on customer experience, product innovation and research methods.
Delivering customer experience in the face of mask wearing.
Ipsos Update
Tracking survey data shows how threats associated with the pandemic and expectations in eight countries have changed over the past year
Our monthly round-up of the latest research and thinking from Ipsos around the world includes new global surveys on life during the pandemic, a new white paper on quality in market research and special features on US and French society.
Our first monthly research round-up of the year includes both reflections on 2020 and a look forward at the year ahead. Featured topics include vaccines, behaviour change, food trends and look at the local story in a selection of countries.
The success of a COVID-19 vaccine is one of the biggest challenges we face globally. This paper explores the opportunities and obstacles that lie ahead.
The final edition of Ipsos Update of 2020 includes research and analysis on key topics including health, sustainability, gender equality and retail. We also look at public opinion on international security and the reputation of different countries around the world.
Our new Ipsos Views paper from Ipsos’ Social Intelligence Analytics team examines the journey of social media data, from tech platforms to research solutions.
Sustainability is not only a relevant topic today, it is the long-term viability of a business.
Barriers and solutions to accelerate V-Comm adoption.
This month’s round-up of research and analysis from Ipsos around the world presents new papers on our learnings from the pandemic, trust in the media, brands and advertising and automotive quality. Explore our new global survey on happiness, the latest ranking of 50 nations’ international image, and much more.
As the race to develop a COVID-19 vaccine continues at speed, the world faces many more questions than answers – not only about when we might have a vaccine, but who will get it first, how will they get it and are they willing to have it? And how far will it take us on the journey back to ‘normal’…?